Search for: "Lupin Pharmaceuticals"
Results 161 - 175
of 175
Sort by Relevance
|
Sort by Date
20 May 2008, 5:33 am
It concerns the patentability of the Beta crystalline form of Imatinib, the active pharmaceutical ingredient in the blockbuster drug Glivec (Gleevec). [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files opposition: Teva… [read post]
18 Apr 2008, 2:00 am
: RealNetworks, Mattel and Hasbro copy the infringer by creating online Scrabble: (IP ThinkTank), Creative Commons Statement of Intent for Attribution-Share Alike Licenses released: (creativecommons.org) Events IP Business Congress – 25-26 June, Amsterdam: (IP Business Congress), INTA annual meeting – 17-21 May, Berlin: (IMPACT), Australia: IPRIA / CELRL / IP Australia: Employees’ IP and the employment relationship – incentives to innovate… [read post]
13 Feb 2008, 6:19 pm
Lupin Pharmaceuticals, Inc., No. 1:2008cv00239, filed January 28, 2008; assigned to J. [read post]
4 Feb 2008, 8:46 am
Lupin argued first that Cobalt forfeited its 180-day exclusivity by entering into a settlement of its patent litigation with King Pharmaceuticals. [read post]
2 Jan 2008, 9:05 pm
Lupin Limited et al Teva Pharmaceutical Industries Ltd. et al v Hetero Drugs Ltd. [read post]
6 Nov 2007, 9:57 pm
In 2005, Lupin Pharmaceuticals submitted the second ANDA with a paragraph IV certification to the '722 patent. [read post]
22 Oct 2007, 10:00 pm
The recent study which I undertook on pharmaceutical lifecycle management yielded some interesting findings apart from decreasing periods of monopoly and earlier patent filings by non-innovators (both of which I have previously written about). [read post]
17 Oct 2007, 10:00 pm
I have just found out from the Generic Pharmaceuticals and IP blog that Teva has now sued 16 companies in relation to its Carvedilol process patents.The 16 defendants are: Zentiva; Mylan; Taro Pharmaceuticals; Lupin; Moehs Iberica; Urquima; Orchid; Wanbury;Z hejiang Huahai; USV Ltd.; Cadila; Ranbaxy; Dr. [read post]
8 Oct 2007, 9:58 pm
In the other letter, Buc & Beardsley wrote to FDA on behalf of its client, Lupin Pharmaceuticals, to request immediate approval of Lupin's ANDA for ramipril capsules. [read post]
20 Sep 2007, 10:05 pm
Lupin, Ltd. and Lupin Pharmaceuticals, Inc., No. 07, Civ. 0632 (D. [read post]
17 Sep 2007, 2:00 pm
Lupin, Ltd. (06-1530). [read post]
12 Sep 2007, 4:59 am
Lupin, LTD., et al. [read post]
Federal Circuit Invalidates Aventis's Altace Patent on Obviousness Grounds, Handing Victory to Lupin
11 Sep 2007, 9:55 pm
Lupin, No. 2006-1530 (Fed. [read post]
24 Jan 2007, 9:59 pm
Teva filed suit against at least the following companies: Cipla; Hetero Drugs; Zydus-Cadila Healthcare; Sandoz; Andrx; Genpharm; Invagen; Lupin; and Apotex. [read post]
